Leading the Way in Life Science Technologies

GEN Exclusives

More »

Market and Technology Analysis

More »
Dec 4, 2013

Next-Generation Sequencing from Research to the Clinic

The opportunities for NGS as a diagnostic tool are immense.

Next-Generation Sequencing from Research to the Clinic

The FDA approved Illumina’s MiSeqDx platform for the clinic in late November. The report below shows how that approval may affect the market. [Select Biosciences]



Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »